Methods of Diagnosis and Prognosis for a Muscular Dystrophy
The invention relates to the treatment, diagnosis, and prognosis of a muscular dystrophy or myopathy. The present inventors have found that the quantity of mu-crystallin is increased in a muscular dystrophy. In particular, the inventors have found that mu-crystallin is increased in facioscapulohumeral muscular dystrophy (FSHD). Based on the inventors' findings, the invention provides a novel means for the treatment, diagnosis, and prognosis of a muscular dystrophy or myopathy.
Attached files:Patents:US 20,090,280,517
Inventor(s):
BLOCH ROBERT J [US]; REED PATRICK W [US]
Type of Offer:
Licensing
« More Diagnostic Patents